Bacterial Infections  >>  Arikayce (amikacin liposome inhalation suspension)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arikayce (amikacin liposome inhalation suspension) / Insmed
NCT01315691 / 2011-000442-38: Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Withdrawn
3
0
NA
Liposomal amikacin for inhalation, Placebo for liposomal amikacin for inhalation
Insmed Incorporated
Cystic Fibrosis
 
 

Download Options